Skip to main content

Advertisement

SpringerLink
Log in

Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration

  • Preclinical study
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Triggering of Toll-like receptor 4 (TLR4) on tumor cells has been found to promote tumor progression by promoting tumor cell proliferation and survival. So far, however, the effect of TLR4 signaling on tumor metastasis has not been well elucidated. Here, we report that triggering of TLR4 on metastatic breast cancer cells could reciprocally regulate the expression of αvβ3 and the expressions of TPM1 and maspin, and promote αvβ3-mediated adhesion and invasive migration of the cells. In metastatic breast cancer cells, TLR4 signaling increased the expression of integrin αvβ3 by activating NF-κB, resulting in the increased adhesion capacity of tumor cells to the ligand for αvβ3, and the increased polymerization of actin and production of MMP-9 in tumor cells in response to ECM. HoxD3 was required for the up-regulation of αv and β3 expressions by NF-κB. Moreover, TLR4 signaling increased the expression of miR-21 in breast cancer cells by activating NF-κB. Accordingly, the expressions of TPM1 and maspin were decreased at protein level, whereas the transcription activity of these genes was not influenced. Consistent with the promoting effect on αvβ3-mediated adhesion and invasive migration, TLR4 signaling promoted the arrest of metastatic breast cancer cells in circulation and following invasion. The effect of TLR4 signaling could be abrogated by inhibiting NF-κB. These findings suggest that metastatic breast cancer cells could acquire higher metastatic potential due to triggering of TLR4 and activation of NF-κB in the cells, and that both TLR4 and NF-κB could be therapeutic targets for preventing metastasis of breast cancer cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572

    Article  PubMed  CAS  Google Scholar 

  2. Felding-Habermann B, O’Toole TE, Smith JW, Fransvea E, Ruggeri ZM, Ginsberg MH, Hughes PE, Pampori N, Shattil SJ, Saven A, Mueller BM (2001) Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci USA 98:1853–1858

    Article  PubMed  CAS  Google Scholar 

  3. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T (2008) SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452:187–193

    Article  PubMed  CAS  Google Scholar 

  4. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY (2008) MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18:350–359

    Article  PubMed  CAS  Google Scholar 

  5. Beauvais DM, Burbach BJ, Rapraeger AC (2004) The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells. J Cell Biol 167:171–181

    Article  PubMed  CAS  Google Scholar 

  6. Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449:682–688

    Article  PubMed  CAS  Google Scholar 

  7. Zheng X, Jiang F, Katakowski M, Zhang ZG, Lu QE, Chopp M (2009) ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation. Cancer Biol Ther 8:1045–1054

    Article  PubMed  CAS  Google Scholar 

  8. Tsan MF, Gao B (2004) Endogenous ligands of Toll-like receptors. J Leukoc Biol 76:514–519

    Article  PubMed  CAS  Google Scholar 

  9. Szczepanski MJ, Czystowska M, Szajnik M, Harasymczuk M, Boyiadzis M, Kruk-Zagajewska A, Szyfter W, Zeromski J, Whiteside TL (2009) Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack. Cancer Res 69:3105–3113

    Article  PubMed  CAS  Google Scholar 

  10. Huang B, Zhao J, Li H, He KL, Chen Y, Chen SH, Mayer L, Unkeless JC, Xiong H (2005) Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 65:5009–5014

    Article  PubMed  CAS  Google Scholar 

  11. Wang EL, Qian ZR, Nakasono M, Tanahashi T, Yoshimoto K, Bando Y, Kudo E, Shimada M, Sano T (2010) High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Br J Cancer 102:908–915

    Article  PubMed  CAS  Google Scholar 

  12. Hua D, Liu MY, Cheng ZD, Qin XJ, Zhang HM, Chen Y, Qin GJ, Liang G, Li JN, Han XF, Liu DX (2009) Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity. Mol Immunol 46:2876–2884

    Article  PubMed  CAS  Google Scholar 

  13. Earl TM, Nicoud IB, Pierce JM, Wright JP, Majoras NE, Rubin JE, Pierre KP, Gorden DL, Chari RS (2009) Silencing of TLR4 decreases liver tumor burden in a murine model of colorectal metastasis and hepatic steatosis. Ann Surg Oncol 16:1043–1050

    Article  PubMed  CAS  Google Scholar 

  14. Szajnik M, Szczepanski MJ, Czystowska M, Elishaev E, Mandapathil M, Nowak-Markwitz E, Spaczynski M, Whiteside TL (2009) TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer. Oncogene 28:4353–4363

    Article  PubMed  CAS  Google Scholar 

  15. Arrighi JF, Rebsamen M, Rousset F, Kindler V, Hauser C (2001) A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol 166:3837–3845

    PubMed  CAS  Google Scholar 

  16. Hood JD, Cheresh DA (2002) Role of integrins in cell invasion and migration. Nat Rev Cancer 2:91–100

    Article  PubMed  Google Scholar 

  17. Gong W, Liu Y, Huang B, Lei Z, Wu FH, Li D, Feng ZH, Zhang GM (2008) Recombinant CBD-HepII polypeptide of fibronectin inhibits alphavbeta3 signaling and hematogenous metastasis of tumor. Biochem Biophys Res Commun 367:144–149

    Article  PubMed  CAS  Google Scholar 

  18. Gong W, Zhang GM, Liu Y, Lei Z, Li D, Yuan Y, Huang B, Feng ZH (2008) IFN-gamma withdrawal after immunotherapy potentiates B16 melanoma invasion and metastasis by intensifying tumor integrin alphavbeta3 signaling. Int J Cancer 123:702–708

    Article  PubMed  CAS  Google Scholar 

  19. Rolli M, Fransvea E, Pilch J, Saven A, Felding-Habermann B (2003) Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci USA 100:9482–9487

    Article  PubMed  CAS  Google Scholar 

  20. Vellon L, Menendez JA, Lupu R (2005) αvβ3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer. Oncogene 24:3759–3773

    Article  PubMed  CAS  Google Scholar 

  21. Karmakar S, Dhar R, Das C (2004) Inhibition of cytotrophoblastic (JEG-3) cell invasion by interleukin 12 involves an interferon gamma-mediated pathway. J Biol Chem 279:55297–55307

    Article  PubMed  CAS  Google Scholar 

  22. Popow A, Nowak D, Malicka-Błaszkiewicz M (2006) Actin cytoskeleton and beta-actin expression in correlation with higher invasiveness of selected hepatoma Morris 5123 cells. J Physiol Pharmacol 57(Suppl 7):111–123

    PubMed  Google Scholar 

  23. Nowak D, Krawczenko A, Duś D, Malicka-Błaszkiewicz M (2002) Actin in human colon adenocarcinoma cells with different metastatic potential. Acta Biochim Pol 49:823–828

    PubMed  CAS  Google Scholar 

  24. Lai TH, Fong YC, Fu WM, Yang RS, Tang CH (2009) Stromal cell-derived factor-1 increase alphavbeta3 integrin expression and invasion in human chondrosarcoma cells. J Cell Physiol 218:334–342

    Article  PubMed  CAS  Google Scholar 

  25. Ohta H, Hamada J, Tada M, Aoyama T, Furuuchi K, Takahashi Y, Totsuka Y, Moriuchi T (2006) HoxD3-overexpression increases integrin αvβ3 expression and deprives E-cadherin while it enhances cell motility in A549 cells. Clin Exp Metastasis 23:381–390

    Article  PubMed  CAS  Google Scholar 

  26. Ruseva Z, Geiger PX, Hutzler P, Kotzsch M, Luber B, Schmitt M, Gross E, Reuning U (2009) Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation. Exp Cell Res 315:1759–1771

    Article  PubMed  CAS  Google Scholar 

  27. Jee BK, Park KM, Surendran S, Lee WK, Han CW, Kim YS, Lim Y (2006) KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line. Biochem Biophys Res Commun 342:655–661

    Article  PubMed  CAS  Google Scholar 

  28. Zheng Q, Safina A, Bakin AV (2008) Role of high-molecular weight tropomyosins in TGF-beta-mediated control of cell motility. Int J Cancer 122:78–90

    Article  PubMed  CAS  Google Scholar 

  29. Khalkhali-Ellis Z, Hendrix MJ (2007) Elucidating the function of secreted maspin: inhibiting cathepsin D-mediated matrix degradation. Cancer Res 67:3535–3539

    Article  PubMed  CAS  Google Scholar 

  30. Pilch J, Habermann R, Felding-Habermann B (2002) Unique ability of integrin alpha(v)beta 3 to support tumor cell arrest under dynamic flow conditions. J Biol Chem 277:21930–21938

    Article  PubMed  CAS  Google Scholar 

  31. Felding-Habermann B (2003) Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis 20:203–213

    Article  PubMed  CAS  Google Scholar 

  32. Tsai YC, Mendoza A, Mariano JM, Zhou M, Kostova Z, Chen B, Veenstra T, Hewitt SM, Helman LJ, Khanna C, Weissman AM (2007) The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation. Nat Med 13:1504–1509

    Article  PubMed  CAS  Google Scholar 

  33. Yang X, Welch DR, Phillips KK, Weissman BE, Wei LL (1997) KAI1, a putative marker for metastatic potential in human breast cancer. Cancer Lett 119:149–155

    Article  PubMed  CAS  Google Scholar 

  34. Kojic LD, Joshi B, Lajoie P, Le PU, Cox ME, Turbin DA, Wiseman SM, Nabi IR (2007) Raft-dependent endocytosis of autocrine motility factor is phosphatidylinositol 3-kinase-dependent in breast carcinoma cells. J Biol Chem 282:29305–29313

    Article  PubMed  CAS  Google Scholar 

  35. Varga AE, Stourman NV, Zheng Q, Safina AF, Quan L, Li X, Sossey-Alaoui K, Bakin AV (2005) Silencing of the Tropomyosin-1 gene by DNA methylation alters tumor suppressor function of TGF-beta. Oncogene 24:4052–5043

    Google Scholar 

  36. Futscher BW, O’Meara MM, Kim CJ, Rennels MA, Lu D, Gruman LM, Seftor RE, Hendrix MJ, Domann FE (2004) Aberrant methylation of the maspin promoter is an early event in human breast cancer. Neoplasia 6:380–389

    Article  PubMed  CAS  Google Scholar 

  37. Zhu S, Si ML, Wu H, Mo YY (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282:14328–14336

    Article  PubMed  CAS  Google Scholar 

  38. Karin M, Cao Y, Greten FR, Li ZW (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301–310

    Article  PubMed  CAS  Google Scholar 

  39. Lee CH, Jeon YT, Kim SH, Song YS (2007) NF-kappaB as a potential molecular target for cancer therapy. Biofactors 29:19–35

    Article  PubMed  CAS  Google Scholar 

  40. Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, Hwang DH (2005) Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol 175:3339–3346

    PubMed  CAS  Google Scholar 

  41. Okubo Y, Hamada J, Takahashi Y, Tada M, Tsutsumida A, Furuuchi K, Aoyama T, Sugihara T, Moriuchi T (2002) Transduction of HoxD3-antisense into human melanoma cells results in decreased invasive and motile activities. Clin Exp Metastasis 19:503–511

    Article  PubMed  CAS  Google Scholar 

  42. Li F, Sethi G (2010) Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. Biochim Biophys Acta 1805:167–180

    PubMed  CAS  Google Scholar 

  43. Baldwin AS (2001) Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 107:241–246

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by National Science Foundation of China (No. 30830095, 30771974, 30772589), and National Development Program (973) For Key Basic Research (No. 2009CB521806) of China.

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, The People’s Republic of China

    Sheng-Jun Liao, Yuan-Hong Zhou, Ye Yuan, Dong Li, Feng-Hua Wu, Qi Wang, Jian-Hua Zhu, Bin Yan, Jing-Jing Wei, Gui-Mei Zhang & Zuo-Hua Feng

Authors
  1. Sheng-Jun Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuan-Hong Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ye Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Feng-Hua Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Qi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jian-Hua Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bin Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jing-Jing Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Gui-Mei Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Zuo-Hua Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zuo-Hua Feng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liao, SJ., Zhou, YH., Yuan, Y. et al. Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration. Breast Cancer Res Treat 133, 853–863 (2012). https://doi.org/10.1007/s10549-011-1844-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-011-1844-0

Keywords

Search

Navigation